Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fesoterodine flexible-dose trial in elderly patients with overactive bladder
2007-007087-17Phase 4Completed
- Sponsor
- Pfizer
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in overactive bladder (OAB) comparing Fesoterodine flexible dose with Placebo (2 arms). Primary endpoint: Change in micturition-related urgency episodes per 24 hours. Started Feb 2008; status: completed.
02
Drugs
fesoterodine
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on 2007-007087-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-007087-17.